For the year ending 2025-10-31, PBSV made $9,001,096 in revenue. -$100,463 in net income. Net profit margin of -1.12%.
| Income Statement | 2025-10-31 | 2024-10-31 | ||
|---|---|---|---|---|
| Revenues | 9,001,096 | 9,509,279 | ||
| Cost of services | 6,091,064 | 6,993,241 | ||
| Gross profit | 2,910,032 | 2,516,038 | ||
| Selling, general and administrative expenses | 3,547,694 | 3,803,625 | ||
| Loss from operations | -637,662 | -1,287,587 | ||
| Other income, net | 543,402 | 532,139 | ||
| Loss before income tax | -94,260 | -755,448 | ||
| Income tax expense | 6,203 | 22,171 | ||
| Net loss | -100,463 | -777,619 | ||
| Basic and diluted loss per share of common stock | -0.004 | -0.034 | ||
| Shares outstanding - basic | 22,947,243 | 22,965,995 | ||
| Shares outstanding - diluted | 22,956,853 | 22,974,124 | ||
Pharma-Bio Serv, Inc. (PBSV)
Pharma-Bio Serv, Inc. (PBSV)